COVI-VAC (codenamed CDX-005) is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving... 6 KB (408 words) - 14:28, 24 August 2023 |
Russian CoviVac; the Kazakh vaccine QazVac; and the Iranian COVIran Barekat. Vaccines in clinical trials include the Valneva COVID‑19 vaccine.[unreliable... 192 KB (22,024 words) - 10:32, 9 May 2024 |
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian... 8 KB (562 words) - 13:12, 26 July 2023 |
its third COVID-19 vaccine, CoviVac". Reuters. 20 February 2021. "A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac". Fortune... 318 KB (19,351 words) - 20:00, 21 April 2024 |
CoviVac may refer to: CoviVac (Russia COVID-19 vaccine), inactivated COVID-19 vaccine developed by the Chumakov Centre in Russia (Russian: КовиВак) Covivac... 694 bytes (132 words) - 09:19, 30 October 2023 |